Literature DB >> 29697503

Measuring the Burden of Opioid-related Mortality in Ontario, Canada.

Tara Gomes1, Simon Greaves, Mina Tadrous, Muhammad M Mamdani, J Michael Paterson, David N Juurlink.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29697503      PMCID: PMC6200374          DOI: 10.1097/ADM.0000000000000412

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


× No keyword cloud information.
To the Editor: Opioid overdose is a leading public health problem across Canada that continues to evolve, particularly as clandestinely-produced opioids enter the market (Public Health Agency of Canada, 2017). In 2014, we published a study that found that 1 in 170 deaths in 2010 was related to opioids, and that this varied by age (Gomes et al., 2014). Given the shifting opioid landscape across Canada, we sought to update this analysis to quantify the burden of opioid-related death in Ontario between 2000 and 2015. To accomplish this, we conducted a cross-sectional study of opioid-related deaths in Ontario, Canada's most populous province. We obtained data on all deaths where prescribed or illicit opioids were determined to be a contributing factor from the Office of the Chief Coroner (Dhalla et al., 2009; Gomes et al., 2011), and used the Ontario Health Insurance Plan (OHIP) Registered Persons Database to determine the total number of deaths from any cause over the study period. Opioid involvement in death was confirmed through post-mortem toxicology and a medical coroner's investigation. The details on this definition have been published previously (Dhalla et al., 2009; Gomes et al., 2011). We examined the burden of opioid-related deaths overall and stratified by age group. We used the Cochran-Armitage test for trend to compare the proportion of deaths in each age group that were opioid-related in each of 4 years (2000, 2005, 2010, and 2015). In a secondary analysis, we used methods adapted from the Global Burden of Disease study (Department of Information Evidence and Research, 2017) to calculate the years of potential life lost (YLL) due to opioid-related deaths using 2015 standard 5-year life expectancy tables developed by the World Health Organization (2017). We did not apply discounting or age weights to align with the World Health Organization's most recent guidance (Department of Information Evidence and Research, 2017). This study was approved by the research ethics board of Sunnybrook Health Sciences Centre, Toronto, Ontario. Between 2000 and 2015, the rate of opioid-related deaths nearly tripled in Ontario (from 19.3 to 53.1 deaths per million population), as did the proportion of deaths attributable to opioids (from 0.3% to 0.8%; Fig. 1). Furthermore, this proportion also increased steadily over time in each age group studied (P < 0.01), with the exception of the 0 to 14-year age group where small numbers precluded analysis. From 2000 to 2015, we observed the largest absolute increase in opioid-attributable mortality in those aged between 25 and 34 years, increasing from 4.6% in 2000 to 15.7% in 2015. However, in the final 5 years of the study period, the most dramatic increase in opioid-attributable mortality occurred among those aged 15 to 24 years (from 6.5% to 11.6% of all deaths).
FIGURE 1

Proportion of deaths that are opioid-related, by age group (2000, 2005, 2010 and 2015). Figure shows the proportion of deaths in each age group that involved an opioid, calculated using opioid-related death data and all-cause mortality data. In Ontario, Canada, opioid-related death data were abstracted from the Office of the Chief Coroner of Ontario, and deaths from all causes were identified using the OHIP Registered Persons Database.

Proportion of deaths that are opioid-related, by age group (2000, 2005, 2010 and 2015). Figure shows the proportion of deaths in each age group that involved an opioid, calculated using opioid-related death data and all-cause mortality data. In Ontario, Canada, opioid-related death data were abstracted from the Office of the Chief Coroner of Ontario, and deaths from all causes were identified using the OHIP Registered Persons Database. In our secondary analysis, we found a total of 29,410 YLL (2.1 YLL/1000 population) due to opioid-related deaths in 2015. The rate was highest among those aged 25 to 34 years (8375 YLL; 4.5 YLL/1000 population) and lowest among those aged 65 and older (555 YLL; 0.3 YLL/1000 population). We found that 1 of every 133 deaths in Ontario in 2015 were opioid-related, and that this burden was highest among young adults, in whom 1 of every 6 deaths was opioid-related. An emerging concerning trend is the large increase in the proportion of deaths attributable to opioids among youth between 2010 and 2015. This highlights an important demographic where additional resources for harm reduction and treatment for opioid use disorder are urgently needed.
  3 in total

1.  Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.

Authors:  Irfan A Dhalla; Muhammad M Mamdani; Marco L A Sivilotti; Alex Kopp; Omar Qureshi; David N Juurlink
Journal:  CMAJ       Date:  2009-12-07       Impact factor: 8.262

2.  Opioid dose and drug-related mortality in patients with nonmalignant pain.

Authors:  Tara Gomes; Muhammad M Mamdani; Irfan A Dhalla; J Michael Paterson; David N Juurlink
Journal:  Arch Intern Med       Date:  2011-04-11

3.  The burden of premature opioid-related mortality.

Authors:  Tara Gomes; Muhammad M Mamdani; Irfan A Dhalla; Stephen Cornish; J Michael Paterson; David N Juurlink
Journal:  Addiction       Date:  2014-07-07       Impact factor: 6.526

  3 in total
  16 in total

1.  A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health Data.

Authors:  Kristen A Morin; Matthiew D Parrotta; Joseph K Eibl; David C Marsh
Journal:  Eur Addict Res       Date:  2021-03-11       Impact factor: 3.015

2.  Potentially Inappropriate Prescribing in Hospitalized Older Adult High-Cost Health Care Users: A Pilot Study.

Authors:  Monica Sanh; Anne Holbrook; Peter D M Macdonald; Justin Lee
Journal:  Can J Hosp Pharm       Date:  2022-07-04

3.  The hepatitis C epidemic in Canada: An overview of recent trends in surveillance, injection drug use, harm reduction and treatment.

Authors:  Lillian Lourenço; Marian Kelly; Jill Tarasuk; Kyla Stairs; Maggie Bryson; Nashira Popovic; Josephine Aho
Journal:  Can Commun Dis Rep       Date:  2021-12-09

4.  Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorder.

Authors:  Rupinder Brar; Christy Sutherland; Seonaid Nolan
Journal:  BMJ Case Rep       Date:  2019-08-01

5.  Comparative efficacy of opioids for older adults presenting to the emergency department with acute pain: Systematic review.

Authors:  Maaike de Vries; Jonathan Gravel; Daphne Horn; Shelley McLeod; Catherine Varner
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275

6.  Comparison of Crude Population-Level Indicators of Opioid Use and Related Harm in New Zealand and Ontario (Canada).

Authors:  Benedikt Fischer; Dimitri Daldegan-Bueno; Wayne Jones
Journal:  Pain Ther       Date:  2020-12-31

7.  Identifying the changing age distribution of opioid-related mortality with high-frequency data.

Authors:  Lauren A Paul; Ye Li; Pamela Leece; Tara Gomes; Ahmed M Bayoumi; Jeremy Herring; Regan Murray; Patrick Brown
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.240

8.  Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.

Authors:  Tara Gomes; Wayne Khuu; Diana Martins; Mina Tadrous; Muhammad M Mamdani; J Michael Paterson; David N Juurlink
Journal:  BMJ       Date:  2018-08-29

9.  Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada.

Authors:  Kristen A Morin; Joseph K Eibl; Joseph M Caswell; Graham Gauthier; Brian Rush; Christopher Mushquash; Nancy E Lightfoot; David C Marsh
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-06-26

10.  "Maybe if I stop the drugs, then maybe they'd care?"-hospital care experiences of people who use drugs.

Authors:  Soo Chan Carusone; Adrian Guta; Samantha Robinson; Darrell H Tan; Curtis Cooper; Bill O'Leary; Karen de Prinse; Grant Cobb; Ross Upshur; Carol Strike
Journal:  Harm Reduct J       Date:  2019-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.